BroadOak Capital Partners
Bill Snider is a Partner at BroadOak Capital Partners since 2006, bringing extensive experience in the investment and life sciences sectors. Snider currently serves on the boards of multiple organizations, including Oligo Factory, Biolog, Inc., Flagship Biosciences, Inc., Halo Labs, and Science and Medicine Group, since 2023 and various years prior. Additionally, Snider is an Advisory Board Member at Reformulate Health and has held board positions at Learning Undefeated and Telesis Bio. Educational credentials include an MBA and a Bachelor of Science in Finance, both from The Wharton School, completed in 1999 and 1991, respectively.
This person is not in any offices
BroadOak Capital Partners
BroadOak Capital Partners, with headquarters in Washington, DC, and San Francisco, is a life-sciences focused boutique financial institution that provides direct investment and investment banking services to companies in research tools and consumables, diagnostics, biopharma services, and adjacent markets. BroadOak has led or participated in investments in more than fifty companies across multiple funds and investment vehicles.